Dr. Eduardo Jule
Technical and Business Consultant, Evolve Consulting
With over two decades of immersion in the dynamic realm of drug delivery, I have cultivated a profound passion for this field since my first encounter in the mid-1990s. Transitioning from pioneering the assessment of naturally derived surfactant emulsification properties in personal care to delving into the intricacies of pharmaceuticals by the end of the decade marked the inception of an exhilarating journey. For six years thereafter, I dedicated myself to pioneering research in polymer-based nanoparticle drug delivery at the University of Tokyo, navigating the realms of academia and cutting-edge nanotech startup NanoCarrier (Tokyo, Japan).
Joining Capsugel in 2004 (Belgium and France) was a pivotal move fuelled by a compelling vision: to promote oral lipid-based formulations as a unique solution to tackle solubility and bioavailability challenges. Over the course of 18 years within the Capsugel and Lonza families (2004-2022), I served diverse roles spanning Business Development, Pharmaceutical Sciences, Pharmaceutical Development, and Regional Sales Leadership.
Throughout my tenure with Capsugel, I spearheaded initiatives that established vibrant customer bases across the EU and the US, authored and delivered impactful presentations and technical brochures as well as scientific publications, and played a pivotal role in the creation of the Lipid Formulation Classification System Consortium, a collaborative endeavor dedicated to elucidating and harnessing the potential of lipid-based drug delivery systems. Central to the LFCS Consortium’s mission was the development and refinement of a standardised evaluation of dispersion and digestion, and the potential extrapolation of in vitro into in vivo performance.
At that time, my expertise culminated in leading a development team that achieved remarkable milestones, from shepherding a new chemical entity through Phase 3 trials to conceptualising formulations that led to groundbreaking patents evidencing the benefits of lipid-based drug delivery.
With a career trajectory spanning startups and corporate landscapes, this journey has seamlessly blended scientific acumen, technical proficiency, and strategic business insight as I moved into Sales Leadership roles (2016-2022), underscored by multilingual fluency and a global perspective honed across 30 years in five countries across three continents. It is this trajectory that led me to create Evolve Consulting in 2022, a consultancy that aims at supporting Pharmaceutical Development through Technical Advisory in drug delivery, Business Development, and Strategic Advisory Services that connect Pharma companies to the right services provider, boost CDMO efforts to create and nurture Customer bases in new markets or spaces, support innovators in building a presence and staying relevant.
